These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 33444574)

  • 41. Protection against experimental pseudomembranous colitis in gnotobiotic mice by use of monoclonal antibodies against Clostridium difficile toxin A.
    Corthier G; Muller MC; Wilkins TD; Lyerly D; L'Haridon R
    Infect Immun; 1991 Mar; 59(3):1192-5. PubMed ID: 1900059
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Fecal microbiota transplantation in the treatment of Clostridium difficile infection: state of the art and literature review.
    Messias BA; Franchi BF; Pontes PH; Barbosa DÁAM; Viana CAS
    Rev Col Bras Cir; 2018; 45(2):e1609. PubMed ID: 29846464
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Fecal microbiota transplantation in recurrent Clostridium difficile infections. Framework and pharmaceutical preparation aspects].
    Batista R; Kapel N; Megerlin F; Chaumeil JC; Barbut F; Bourlioux P; Chast F
    Ann Pharm Fr; 2015 Sep; 73(5):323-31. PubMed ID: 25825054
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Asymptomatic carriage of Clostridium difficile and serum levels of IgG antibody against toxin A.
    Kyne L; Warny M; Qamar A; Kelly CP
    N Engl J Med; 2000 Feb; 342(6):390-7. PubMed ID: 10666429
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Development of a new serological assay for the diagnosis of Clostridium difficile infections with prognostic value.
    von Bechtolsheim F; Varga A; Szereday L; Polgar B; Balassa T; Kocsis B; Peterfi Z; Miko E
    J Microbiol Methods; 2019 Dec; 167():105777. PubMed ID: 31733265
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Clostridium difficile lacks detectable superantigen activity.
    Wanahita A; Davis B; Hamill RJ; Goldsmith EA; Rodgers JR; Cook RG; Lamphear JG; Musher DM
    FEMS Immunol Med Microbiol; 2006 Jul; 47(2):275-7. PubMed ID: 16831215
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Immune Thrombocytopenia Caused by Fecal Microbial Transplantation in a Patient With Severe Recurrent Clostridium difficile Infection.
    Malnick SD; Oppenheim A; Melzer E
    J Clin Gastroenterol; 2015; 49(10):888-9. PubMed ID: 26302500
    [No Abstract]   [Full Text] [Related]  

  • 48. Non-invasive fecal microbiota transplantation for recurrent Clostridium difficile infection in a patient presenting with hypertensive disorder post interventionem.
    Goeser F; Schlabe S; Ruiner CE; Kramer L; Strassburg CP; Spengler U
    Z Gastroenterol; 2016 Oct; 54(10):1143-1146. PubMed ID: 27644000
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Sensitive assays enable detection of serum IgG antibodies against Clostridium difficile toxin A and toxin B in healthy subjects and patients with Clostridium difficile infection.
    Zhao X; Bender F; Shukla R; Kang JJ; Caro-Aguilar I; Laterza OF
    Bioanalysis; 2016 Apr; 8(7):611-23. PubMed ID: 26964649
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Fecal transplant for Clostridium difficile infection relapses using "pooled" frozen feces from non-related donors.
    Gutiérrez-Delgado EM; Garza-González E; Martínez-Vázquez MA; González-González JA; Maldonado-Garza HJ; Mendoza-Olazaran S; Hernández-Balboa CL; Camacho-Ortiz A
    Acta Gastroenterol Belg; 2016; 79(2):268-70. PubMed ID: 27382953
    [No Abstract]   [Full Text] [Related]  

  • 51. Association between antibody response to toxin A and protection against recurrent Clostridium difficile diarrhoea.
    Kyne L; Warny M; Qamar A; Kelly CP
    Lancet; 2001 Jan; 357(9251):189-93. PubMed ID: 11213096
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Human monoclonal antibodies directed against toxins A and B prevent Clostridium difficile-induced mortality in hamsters.
    Babcock GJ; Broering TJ; Hernandez HJ; Mandell RB; Donahue K; Boatright N; Stack AM; Lowy I; Graziano R; Molrine D; Ambrosino DM; Thomas WD
    Infect Immun; 2006 Nov; 74(11):6339-47. PubMed ID: 16966409
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Freeze-dried, Capsulized Fecal Microbiota Transplantation for Relapsing Clostridium difficile Infection.
    Tian H; Ding C; Gong J; Wei Y; McFarland LV; Li N
    J Clin Gastroenterol; 2015 Jul; 49(6):537-8. PubMed ID: 25955501
    [No Abstract]   [Full Text] [Related]  

  • 54. Antigenicity of amino-acid sequences from Clostridium difficile toxin B.
    Torres JF; Monath TP
    J Med Microbiol; 1996 Jun; 44(6):464-74. PubMed ID: 8636964
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Human C. difficile toxin-specific memory B cell repertoires encode poorly neutralizing antibodies.
    Shah HB; Smith K; Scott EJ; Larabee JL; James JA; Ballard JD; Lang ML
    JCI Insight; 2020 Aug; 5(16):. PubMed ID: 32663199
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Fecal microbiota transplantation via colonoscopy for recurrent C. difficile Infection.
    Allegretti JR; Korzenik JR; Hamilton MJ
    J Vis Exp; 2014 Dec; (94):. PubMed ID: 25549239
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The growth of faecal microbiota transplantation in the UK: time for a registry?
    Inglis D; Quraishi MN; Green C; Iqbal T
    Lancet Gastroenterol Hepatol; 2022 Feb; 7(2):112-114. PubMed ID: 35026167
    [No Abstract]   [Full Text] [Related]  

  • 58. Systemic antibody responses induced by a two-component Clostridium difficile toxoid vaccine protect against C. difficile-associated disease in hamsters.
    Anosova NG; Brown AM; Li L; Liu N; Cole LE; Zhang J; Mehta H; Kleanthous H
    J Med Microbiol; 2013 Sep; 62(Pt 9):1394-1404. PubMed ID: 23518659
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Association of interleukin-8 polymorphism and immunoglobulin G anti-toxin A in patients with Clostridium difficile-associated diarrhea.
    Jiang ZD; Garey KW; Price M; Graham G; Okhuysen P; Dao-Tran T; LaRocco M; DuPont HL
    Clin Gastroenterol Hepatol; 2007 Aug; 5(8):964-8. PubMed ID: 17618838
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Concurrence of Clostridium difficile toxin A enzyme-linked immunosorbent assay, fecal lactoferrin assay, and clinical criteria with C. difficile cytotoxin titer in two patient cohorts.
    Schleupner MA; Garner DC; Sosnowski KM; Schleupner CJ; Barrett LJ; Silva E; Hirsch D; Guerrant RL
    J Clin Microbiol; 1995 Jul; 33(7):1755-9. PubMed ID: 7665642
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.